Your Location：
Home >
Browse articles >
Danlou Tablet (丹蒌片) Improves Chronic Intermittent Hypoxia-induced Dyslipidemia and Arteriosclerosis by HIF-1 α-Angptl4 mRNA Signaling Pathway
OriginalPaper | Updated：2021-09-24
|

    • Danlou Tablet (丹蒌片) Improves Chronic Intermittent Hypoxia-induced Dyslipidemia and Arteriosclerosis by HIF-1 α-Angptl4 mRNA Signaling Pathway

    • Danlou Tablet (丹蒌片) Improves Chronic Intermittent Hypoxia-induced Dyslipidemia and Arteriosclerosis by HIF-1 α-Angptl4 mRNA Signaling Pathway

    • 中国结合医学杂志（英文版）   页码：1-9

    Scan for full text

  • Jing-jing Tang, Guang-xi Li, Zhi-guo Liu, 等. Danlou Tablet (丹蒌片) Improves Chronic Intermittent Hypoxia-induced Dyslipidemia and Arteriosclerosis by HIF-1 α-Angptl4 mRNA Signaling Pathway[J/OL]. 1-9. DOI：

    Jing-jing Tang, Guang-xi Li, Zhi-guo Liu, et al. Danlou Tablet (丹蒌片) Improves Chronic Intermittent Hypoxia-induced Dyslipidemia and Arteriosclerosis by HIF-1 α-Angptl4 mRNA Signaling Pathway[J/OL]. 1-9. DOI：

  •  
  •  
FULL TEXT LINK
More>

0

浏览量

0

Downloads

1

CSCD

文章被引用时，请邮件提醒。
Submit
工具集
参考文献导出
分享
收藏
添加至我的专辑

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据
0